| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | Director | CEO
1 company
Collier Alan Brian is a CEO at ENDONOVO THERAPEUTICS, INC.. Recent SEC Form 4 filings include 141 buys and 0 sells.
Estimated insider holdings value: $3 based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 54,500 | $0.02 | $1,098.65 | - | |
| Mar 12, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 21,000 | $0.02 | $413.05 | - | |
| Mar 7, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 103,500 | $0.02 | $2,039.65 | - | |
| Mar 4, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 46,500 | $0.02 | $965.95 | - | |
| Feb 26, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 40,000 | $0.02 | $889.30 | - | |
| Feb 21, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 50,000 | $0.02 | $1,159.00 | - | |
| Feb 15, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 17,000 | $0.02 | $389.00 | - | |
| Feb 15, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 174,000 | $0.02 | $3,931.60 | - | |
| Feb 12, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 213,000 | $0.02 | $4,806.50 | - | |
| Feb 12, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 17,500 | $0.02 | $390.25 | - |